Anupam Rasayan India vs Neogen Chemicals: Share Price, Comparison and Key Differences
- August 11, 2026
- Posted by: Neeraj Pandey
- Category: News
Anupam Rasayan India MCap Rs 13,794 Cr, PE 62.07x, ROE 5.10%, D/E 0.56. Neogen Chemicals MCap Rs 5,556 Cr, PE 156.21x (very thin earnings), ROE 3.52%, D/E 1.71.
Anupam Rasayan India vs Neogen Chemicals is a comparison specialty chemical investors look up when evaluating two listed Indian specialty chemical companies facing similar challenges. Anupam Rasayan India, a Surat-based specialty chemical company, makes life science intermediates – fluorine-based and chloro-sulphonation chemistry products – for global agrochemical and pharmaceutical innovator companies. Neogen Chemicals, a Mumbai-based company, specialises in organic bromine compounds and lithium compounds, serving agrochemicals, pharmaceuticals and battery manufacturers. Both Anupam Rasayan vs Neogen Chemicals are in thin-earnings phases reflecting specialty chemical sector headwinds.
This Anupam Rasayan India vs Neogen Chemicals article covers reach and market position, key products, latest declared results and stock valuation. The Anupam Rasayan India vs Neogen Chemicals data below is sourced from Groww and public company filings and reflects the most recently available information at the time of writing.
Anupam Rasayan India vs Neogen Chemicals: Reach and Market Position
On the Anupam Rasayan India side of the Anupam Rasayan India vs Neogen Chemicals comparison, Anupam Rasayan supplies life science specialty chemicals to global agrochemical and pharma innovator companies in Europe and Japan. Market capitalisation is Rs 13,794 Cr.
Click Here – Get Free Investment Predictions
On the Neogen Chemicals side of the Anupam Rasayan India vs Neogen Chemicals comparison, Neogen Chemicals supplies organic bromines and lithium compounds to agrochemicals, pharmaceuticals and lithium battery manufacturers in India and for export. Market capitalisation is Rs 5,556 Cr.
Anupam Rasayan India vs Neogen Chemicals: Key Products and Business Mix
In the Anupam Rasayan India vs Neogen Chemicals product comparison, Anupam Rasayan India offers: Anupam Rasayan earns from custom synthesis of agrochemical and pharma intermediates using fluorine and chloro-sulphonation chemistry. EPS is Rs 19.52. PE is 62.07x, ROE 5.10 percent, D/E 0.56.
For Neogen Chemicals in this Anupam Rasayan India vs Neogen Chemicals breakdown: Neogen Chemicals earns from organic bromine derivatives and lithium compounds (lithium hydroxide, lithium chloride, organolithium). EPS is Rs 12.99. PE is 156.21x (very thin earnings!), ROE 3.52 percent, D/E 1.71.
Anupam Rasayan India vs Neogen Chemicals: Latest Results
The Anupam Rasayan India vs Neogen Chemicals results for Anupam Rasayan India: Anupam Rasayan has a market cap of Rs 13,794 Cr and PE of 62.07x. ROE is 5.10 percent. Both companies are in a thin-earnings phase. Anupam is 2.5 times larger than Neogen Chemicals.
The Anupam Rasayan India vs Neogen Chemicals results for Neogen Chemicals: Neogen Chemicals has a market cap of Rs 5,556 Cr and PE of 156.21x (extremely thin earnings). ROE is 3.52 percent. D/E is 1.71 – the highest debt level among this pair. Neogen’s high PE reflects investor expectation of earnings recovery.
Compare Anupam Rasayan India and Neogen Chemicals Fundamentals on the Univest Screener
Anupam Rasayan India vs Neogen Chemicals: Stock and Valuation
The Anupam Rasayan India vs Neogen Chemicals stock comparison uses the latest available market data from Groww. Investors tracking Anupam Rasayan India vs Neogen Chemicals should verify current prices on NSE or BSE before trading.
Anupam Rasayan vs Neogen Chemicals at current valuations: Anupam trades at Rs 13,794 Cr market cap, PE 62.07x, ROE 5.10 percent. Neogen trades at Rs 5,556 Cr market cap, PE 156.21x (thin), ROE 3.52 percent, D/E 1.71. Both have thin earnings. Anupam has a marginally higher ROE and lower debt.
Anupam Rasayan India vs Neogen Chemicals: Quick Comparison Table
The Anupam Rasayan India vs Neogen Chemicals comparison table below summarises the key metrics covered in this article side by side.
| Parameter | Anupam Rasayan India | Neogen Chemicals |
|---|---|---|
| Sector | Custom synthesis: fluorine and chloro-sulphonation chemistry (agro + pharma) | Organic bromine compounds + lithium compounds (agro, pharma, batteries) |
| Market Cap | Rs 13,794 Cr | Rs 5,556 Cr |
| P/E Ratio | 62.07x (thin earnings) | 156.21x (very thin earnings) |
| ROE | 5.10% | 3.52% |
| Debt to Equity | 0.56 | 1.71 |
| Key Chemistry | Fluorine + chloro-sulphonation chemistry | Organic bromine + lithium compounds |
| Clients | Global innovator agro and pharma (long-term CSA) | Domestic and export agro + battery manufacturers |
Conclusion
The Anupam Rasayan India vs Neogen Chemicals comparison above covers the key data points on reach, products, results and valuation. Anupam Rasayan India vs Neogen Chemicals covers two specialty chemical companies in thin-earnings phases due to sector headwinds. Anupam Rasayan is a custom synthesis specialist for agro and pharma innovators. Neogen has a unique bromine and lithium chemistry platform. Anupam vs Neogen investors should review customer retention, new long-term supply agreements, capacity utilisation and lithium battery demand recovery for Neogen. Anupam Rasayan vs Neogen Chemicals are both specialty chemical recovery plays. Consult a SEBI-registered advisor for personalised guidance.
Download the Univest iOS App or Univest Android App to track Anupam Rasayan India and Neogen Chemicals live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information, including company results filings and exchange data, and are current as of the time of writing. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What does Anupam Rasayan make?
Ans. Anupam Rasayan makes specialty chemical intermediates for agrochemicals and pharmaceuticals using fluorine-based chemistry and chloro-sulphonation. It works under long-term customer supply agreements (CSAs) with global innovator companies in Japan and Europe.
What does Neogen Chemicals make?
Ans. Neogen Chemicals makes organic bromine compounds (used in agrochemicals, flame retardants, pharmaceuticals) and lithium compounds (lithium hydroxide, lithium chloride, organolithium) used in pharmaceutical synthesis and lithium battery manufacturing.
Why are their PEs so high?
Ans. Both Anupam Rasayan (PE 62x) and Neogen Chemicals (PE 156x) have high PEs because earnings are near cyclical lows from specialty chemical sector headwinds. The market expects earnings to recover – investors pay today’s price for tomorrow’s normalised earnings.
What is a CSA?
Ans. A CSA (Customer Supply Agreement) is a long-term binding contract between a specialty chemical company and a global innovator where the chemical company agrees to supply a specific intermediate exclusively. CSAs provide multi-year revenue visibility.
Are Anupam Rasayan and Neogen in Nifty 50?
Ans. Neither is in Nifty 50. Both are tracked in smaller indices.
Which has more debt, Anupam or Neogen?
Ans. Neogen Chemicals has a much higher D/E of 1.71 versus Anupam Rasayan’s 0.56. Neogen’s higher debt reflects its lithium compound capacity investment.
Which is larger, Anupam Rasayan or Neogen?
Ans. Anupam Rasayan at Rs 13,794 Cr is approximately 2.5 times larger than Neogen Chemicals at Rs 5,556 Cr.
